Delivery Order SPE2DB20D1004-SPE2DB25FNEMH
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,156.98, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for diabetes management. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,128.12, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a type 2 diabetes medication. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,558.98, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for the treatment of diabetes. The contract has an ultimate completion date of February 24, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,728.30, is for the provision of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,148.35 contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to manage diabetes. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,015.94, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract has an ultimate completion date of October 16, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,699.95, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,685.06, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials to support federal healthcare programs. The contract has an ultimate completion date of January 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,569.87, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,716.14, is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of February 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...